Medical Packaging Company (EGX: MEPA)
Egypt
· Delayed Price · Currency is EGP 1.340
+0.010 (0.75%)
At close: Dec 19, 2024
Medical Packaging Company Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 132.28 | 91.02 | 59.24 | 47.01 | 36.73 | 29.76 | Upgrade
|
| Revenue Growth (YoY) | 90.20% | 53.65% | 26.03% | 27.97% | 23.42% | 28.19% | Upgrade
|
| Cost of Revenue | 71.11 | 47.42 | 39.22 | 33.17 | 27.68 | 19.85 | Upgrade
|
| Gross Profit | 61.18 | 43.6 | 20.02 | 13.84 | 9.05 | 9.91 | Upgrade
|
| Selling, General & Admin | 7.77 | 6.97 | 4.47 | 4.84 | 4.28 | 3.62 | Upgrade
|
| Operating Expenses | 10.5 | 6.97 | 4.47 | 4.84 | 4.31 | 4.32 | Upgrade
|
| Operating Income | 50.68 | 36.63 | 15.56 | 9 | 4.74 | 5.59 | Upgrade
|
| Interest Expense | - | - | -0.87 | -0.37 | - | - | Upgrade
|
| Interest & Investment Income | 10.67 | 8.95 | 0.76 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -11.67 | -17.56 | -0.24 | 0.02 | -0.04 | 0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -11 | -20.88 | 3.02 | -0.31 | -0.39 | 0.07 | Upgrade
|
| EBT Excluding Unusual Items | 38.67 | 7.13 | 18.22 | 8.34 | 4.31 | 5.85 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.03 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | - | -0.03 | Upgrade
|
| Pretax Income | 38.67 | 7.13 | 18.25 | 8.34 | 4.31 | 5.83 | Upgrade
|
| Income Tax Expense | 13.34 | 5.03 | 12.51 | 0.66 | -0.1 | 0.28 | Upgrade
|
| Net Income | 25.33 | 2.1 | 5.74 | 7.68 | 4.41 | 5.55 | Upgrade
|
| Net Income to Common | 25.33 | 2.1 | 5.74 | 7.68 | 4.41 | 5.55 | Upgrade
|
| Net Income Growth | 167.32% | -63.36% | -25.27% | 74.25% | -20.60% | 370.70% | Upgrade
|
| Shares Outstanding (Basic) | 66 | 66 | 345 | 345 | 345 | 320 | Upgrade
|
| Shares Outstanding (Diluted) | 66 | 66 | 345 | 345 | 345 | 320 | Upgrade
|
| Shares Change (YoY) | -88.62% | -80.96% | - | - | 7.81% | - | Upgrade
|
| EPS (Basic) | 0.39 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | Upgrade
|
| EPS (Diluted) | 0.39 | 0.03 | 0.02 | 0.02 | 0.01 | 0.02 | Upgrade
|
| EPS Growth | 2250.03% | 92.41% | -25.27% | 74.25% | -26.36% | 370.77% | Upgrade
|
| Free Cash Flow | 41.36 | 6.61 | 23.46 | 10.01 | 2.07 | -1.01 | Upgrade
|
| Free Cash Flow Per Share | 0.63 | 0.10 | 0.07 | 0.03 | 0.01 | -0.00 | Upgrade
|
| Gross Margin | 46.25% | 47.90% | 33.80% | 29.44% | 24.64% | 33.30% | Upgrade
|
| Operating Margin | 38.31% | 40.24% | 26.26% | 19.14% | 12.91% | 18.77% | Upgrade
|
| Profit Margin | 19.15% | 2.31% | 9.69% | 16.33% | 12.00% | 18.65% | Upgrade
|
| Free Cash Flow Margin | 31.26% | 7.26% | 39.60% | 21.29% | 5.64% | -3.38% | Upgrade
|
| EBITDA | 55.8 | 41.69 | 19.85 | 12.67 | 8.09 | 8.02 | Upgrade
|
| EBITDA Margin | 42.19% | 45.81% | 33.51% | 26.96% | 22.03% | 26.96% | Upgrade
|
| D&A For EBITDA | 5.13 | 5.07 | 4.3 | 3.68 | 3.35 | 2.44 | Upgrade
|
| EBIT | 50.68 | 36.63 | 15.56 | 9 | 4.74 | 5.59 | Upgrade
|
| EBIT Margin | 38.31% | 40.24% | 26.26% | 19.14% | 12.91% | 18.77% | Upgrade
|
| Effective Tax Rate | 34.50% | 70.53% | 68.56% | 7.90% | - | 4.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.